Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-21
2006-11-21
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S342000, C514S343000, C514S374000, C514S408000, C546S208000, C546S209000, C546S269700, C546S276400, C548S146000, C548S566000
Reexamination Certificate
active
07138416
ABSTRACT:
The invention discloses a novel series of compound represented by general formula (I),its derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, pharmaceutically acceptable salts, and solvates wherein X, n, k, z, R1, R2, R3, R4, R5 and R6 are as defined in the specification that are useful in (i) normalizing elevated blood glucose levels in diabetics, (ii) treating disorders related to glucose intolerance and (iii) for scavenging free radicals in mammals.
REFERENCES:
patent: 6172081 (2001-01-01), Damon
patent: WO 95/15309 (1995-06-01), None
patent: 99/62888 (1999-12-01), None
patent: WO 02/34243 (2002-05-01), None
patent: WO 03/002595 (2003-01-01), None
J.A. Pospisilik et al., Long-Term Treatment with the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and β-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats, Diabetes, vol. 51, Apr. 2002, pp. 943-950.
Vincent Marks, et al., Rapid Stick Method for Determining Blood-glucose Concentration, British Medical Journal, Jan. 30, 1965, Sputum vol., pp. 293-294.
Bernard Portha, et al., The Neonatally Streptozotocin-Induced (n-STZ) Diabetic Rats, A Family of Niddm Models, Harwood Academic Publishers, 2001, pp. 247-271.
Augustyns K. et al. Current Medical Chemistry 1999;6:311-327.
Bork Balkan and Xue Li : Am J Physiol Regulatory Integrative Comp Physiol 279:R 1449-R1454, 2000.
Balkan B. et al. Diabetologia (1999) 42:1324-1331.
Brubaker P.L. et al. Am. J. Physiol. 1997;272:E1050-1058.
Browne SE et al. Brain Pathology (1999) 9;147-163.
Carolyn FD, et al. Diabetes 47:764-769, 1998.
Doyle ME and Egan JM: Recent Prog Horm Res 56:377-399, 2001.
Drucker, D.J. Diabetes 1998: 47:159-169.
Gang et.al., Diabetes, vol. 48, Dec. 1999; 2270-2276.
Harold E Lebovitz, Drug Benefit Trends 12 (supp A):8-16, 2000, 1-12.
Harper E.J. The 24thAnnual Waltham® /OSU Symposium—Oct. 28-29, 2000.
Holst JJ and Deacon CF : Diabetes, 47:1663-1670, 1998.
Ishii et. al. Journal of Gastroenterology and Hepatology (1997) 12 (Suppl.), S272-S282.
Korom S. et al. Transplantation 1997;63:1495-1500.
MacNee W, Rahman I, Trends Mol Med 2001 Feb;7(2):55-62.
Maxwell et. al, Br J Clin Pharmacol 1997; 44:307-317.
Mentlein Rolf : Regulatory Peptides 85 (1999) 9-24.
Michael A Nauck : Diabetologia. 42:373-379, 1999.
Michael Berelowitz and Ione A Kourides : Diabetes mellitus secondary to other endocrine disorders in Diabetes Mellitus : A fundamental and clinical text, second edition : Lippincott Williams & Wilkins, p. 588-593, 2000.
Munch G et.al, J Neural Transm (1998) 105:439-461.
Nguyen C et al. J Med Chem 1998; 41:2100-2110.
Qualmann C et al. Acta Diabetol 1995; 32: 13-16.
Raymond AP, et al : Diabetes 47:1253-1258, 1998.
Robert PP, et al : Metabolism 48:385-389, 1999.
Ronald A DeLellis: The Endocrine system in Robbins pathologic basis of disease, fourth edition, W.B. Saunders international edition, p. 1205, 1254-1255, 1989.
Ronald T Jung : Obesity and nutritional factors in the pathogenesis of non-insulin-dependent diabetes mellitus. Textbook of diabetes, second edition vol. 1, :Blackwell science, p. 19.12, 19.13-19.14, 1997.
Rosenfeld ME et.al. Arterioscler Thromb Vasc Biol Sep. 1998;18(9):1506-13.
Sedo A and Kraml J : Sborn Iek, 95(4):285-288, 1994.
Siegel EG, et al. : Eur J Clin Invest 29(7):610-614, 1999.
Smith M A , Biochim Biophys Acta Jul. 26, 2000; 1502(1):139-144.
Tina Vilsbol! et al. : Diabetes 50:609-613, 2001.
Tiruppathi, C., et al., Am. J. Physiol. 1993;265:G81-89.
Zalba G. et. al., J physiol Biochem, 56(1) 2000;57-64.
Solola Taofiq
Torrent Pharmaceuticals Ltd.
LandOfFree
Compounds and therapeutic uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compounds and therapeutic uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds and therapeutic uses thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3665476